Palvella Therapeutics (PVLA) Non-Current Assets (2013 - 2026)

Palvella Therapeutics (PVLA) has reported Non-Current Assets for 13 consecutive years, with $528000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets changed N/A year-over-year to $528000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 283.28% YoY), while the FY2025 annual figure was $572000.0, changed N/A from the prior year.
• Non-Current Assets slipped to $528000.0 in Q1 2026 per PVLA's latest filing, from $572000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $25.4 million in Q1 2022 and bottomed at $287000.0 in Q3 2023.
• Historically, Non-Current Assets has averaged $15.1 million across 4 years, with a median of $21.1 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Assets fell 7.81% — and 2023, when it slumped 98.61%.
• Palvella Therapeutics' Non-Current Assets stood at $22.1 million in 2022, then slumped by 98.7% to $287000.0 in 2023, then soared by 99.3% to $572000.0 in 2025, then slipped by 7.69% to $528000.0 in 2026.
• Business Quant data shows PVLA's Non-Current Assets at $528000.0 in Q1 2026, $572000.0 in Q4 2025, and $287000.0 in Q3 2023.